1,056 results on '"Falkenburg, J"'
Search Results
2. Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens
3. Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients
4. Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain
5. What Defines a Good Tumour Antigen?
6. Hotspot DNA Methyltransferase 3A (DNMT3A) and Isocitrate Dehydrogenase 1 and 2 (IDH1/2) Mutations in Acute Myeloid Leukemia and Their Relevance as Targets for Immunotherapy
7. Self-sufficient primary natural killer cells engineered to express T cell receptors and interleukin-15 exhibit improved effector function and persistence
8. Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM
9. Delayed Transfer of Immune Cells or the Art of Donor Lymphocyte Infusion
10. Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation
11. Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation—a phase I/II study
12. Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion
13. TCR targeting hematopoiesis to cure leukemia
14. Apoptin Induces Apoptosis in Human Transformed and Malignant Cells but not in Normal Cells
15. Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma
16. Delayed Transfer of Immune Cells or the Art of Donor Lymphocyte Infusion
17. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT
18. Mass cytometric analysis unveils a disease-specific immune cell network in the bone marrow in acquired aplastic anemia.
19. PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer
20. Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing
21. Therapeutic targeting of the BCR-associated protein CD79b in a TCR-based approach is hampered by aberrant expression of CD79b
22. Donor T-cell responses and disease progression patterns of multiple myeloma
23. A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma
24. Human T cells recognize HLA-DP–bound peptides in two orientations
25. Joint models quantify associations between immune cell kinetics and alloimmunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion.
26. Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses
27. Characterization of the T-Cell-Mediated Immune Response Against the Aspergillus fumigatus Proteins Crf1 and Catalase 1 in Healthy Individuals
28. Fetal Hematopoiesis During First and Second Trimester of Pregnancy: Relevance for In Utero Stem Cell Transplantation
29. Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure
30. Plastic CD34 and CD38 expression in adult B-cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations
31. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
32. WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma
33. S232: EXPANDING THE REPERTOIRE OF HLA CLASS I-RESTRICTED MINOR HISTOCOMPATIBILITY ANTIGENS FOR IMMUNE MONITORING AND MODULATION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
34. Cutting Edge: Unconventional CD8+ T Cell Recognition of a Naturally Occurring HLA-A*02:01–Restricted 20mer Epitope
35. Umbilical Cord Blood as an Alternative Source of Haematopoietic Stem Cells for Transplantation
36. Mixed T cell receptor dimers harbor potentially harmful neoreactivity
37. Identification of Phosphatidylinositol 4-Kinase Type II β as HLA Class II-Restricted Target in Graft versus Leukemia Reactivity
38. National Cancer Institute’s First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Summary and Recommendations from the Organizing Committee
39. Public T-Cell Receptors (TCRs) Revisited by Analysis of the Magnitude of Identical and Highly-Similar TCRs in Virus-Specific T-Cell Repertoires of Healthy Individuals
40. T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion
41. Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity
42. Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure
43. Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL
44. SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross-reactive CMV-specific T cells.
45. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT
46. A mechanistic rationale for combining alemtuzumab and rituximab in the treatment of ALL
47. Co-ordinated isolation of CD8+ and CD4+ T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy
48. Allo-HLA reactivity of virus-specific memory T cells is common
49. High Levels of Circulating Hematopoietic Progenitor Cells after Continuous Infusion of High Dose Interleukin-2 in Cancer Patients
50. Allo-reactive T cells for the treatment of hematological malignancies☆
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.